Allegra Product Information
Seasonal allergies can make it difficult for you to enjoy what you’re doing. Allegra can help you feel better by relieving allergy symptoms in patients 12 and over, so you can more fully enjoy your world.TM
Visit our PRODUCT INFORMATION section to learn about:
- Once-daily Allegra® (fexofenadine HCI) 180-mg tablets for seasonal allergic rhinitis in patients 12 and older. NOW AVAILABLE
- Allegra® (fexofenadine HCI) 60-mg tablets & capsules for seasonal allergic rhinitis and chronic idiopathic urticaria hives in patients 12 and older.
- Allegra® (fexofenadine HCI) a pediatric formulation of 30-mg tablets for seasonal allergies and hives for pediatric patients 6-11 years.
- Allegra-D® (fexofenadine HCI 60-mg/pseudoephedrine HCI 120 mg) extended-release tablets for seasonal allergies with nasal congestion in patients 12 and older.
Don’t miss these sections here on our Allegra web site to help you discover the allergy relief you’ve been looking for:
- LEARN ABOUT ALLERGIES – find in-depth articles about seasonal allergies, a Glossary of common allergy terminology, Inside Allergies, a cellular animation of what happens in your body during an allergic reaction, and more.
- POLLEN FORECAST – Is it an allergy day? Before you go out check for a daily update on pollen counts for your local area.
- WHY ALLEGRA? – Claritin® and Zyrtec® users will want to check out this section.
| Now Allegra® is Available in 180 mg tablets Take just one tablet once daily for 24-hour seasonal allergy relief in patients 12 and older! |
Now, Allegra introduces the convenience of long lasting, once-daily seasonal allergy relief with Allegra 180 mg tablets. Imagine the freedom: you take just one Allegra 180 mg tablet once daily for 24-hour seasonal allergy relief!
Allegra is an effective antihistamine that contains fexofenadine—a unique ingredient that combats your seasonal allergy symptoms: itchy, watery eyes. Plus sneezing and runny nose. But unlike some allergy medications, Allegra won’t make you drowsy. In fact, in clinical studies, drowsiness in people who took Allegra 180 mg tablets was similar to placebo (sugar pill), 0.4% vs. 0.0%.
The other formulations of Allegra are also similar to placebo: 60-mg capsules ( 1.3% vs. 0.9%), and 30-mg tablets (0.5% vs. 0.9%).
Claritin, is a registered trademarks of Schering Corporation. Zyrtec is a registered trademark of UCB, Societe Anonyme.
IMPORTANT SAFETY INFORMATION
The most commonly reported adverse events with once-daily Allegra 180-mg tablets and placebo in seasonal allergy patients 12 and older are headache (10.6% vs. 7.5%), upper respiratory tract infection (3.2% vs. 3.1%), and back pain (2.8% vs. 1.4%).
The most commonly reported adverse experiences for Allegra 60-mg capsules and tablets and placebo in seasonal allergy patients 12 and older are cold, flu (2.5% vs. 1.5%), nausea (1.6% vs. 1.5%), and menstrual pain (1.5% vs. 0.3%).
The most commonly reported adverse events with Allegra 30-mg twice daily and placebo in seasonal allergy patients 6-11 years are headache (7.2% vs. 6.6%), upper respiratory tract infection (4.3 % vs. 1.7%), coughing (3.8% vs. 1.3%), and accidental injury (2.9% vs. 1.3%).
Because Allegra-D (fexofenadine HCl 60mg/pseudoephedrine HCl 120mg) extended-release tablets contain pseudoephedrine (the decongestant in most over-the-counter allergy medicines), Allegra-D must not be taken if you are also taking MAO inhibitors (medicines that treat depression) or if you retain urine or have glaucoma, severe high blood pressure, or severe heart disease. Also, let your doctor know before you take Allegra-D if you have high blood pressure, diabetes, heart disease, glaucoma, thyroid disease, impaired kidney function, or symptoms of an enlarged prostate such as difficulty urinating. The most commonly reported adverse experiences with twice-daily Allegra-D extended release tablets compared to pseudoephedrine alone in seasonal allergic rhinitis with nasal congestion in patients 12 and older were headache (13.0% vs. 17.4%), insomnia (12.6% vs. 13.3%), and nausea (7.4% vs. 5.0%).